Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer

doi:10.4251/wjgo.v12.i8.903

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5468)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

369

WORD

191

HTML

2703

Figures (1-2)

240

Tables (1-3)

189

Sum=3692

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

641

Download

1135

Sum=1776

Aug 15, 2020 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Aug 15, 2020; 12(8): 903-917
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.903

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Maier: 5-year overall survival after cytoreductive surgery + hyperthermic intraperitoneal chemotherapy depending on different outcome factors. Univariate analysis of survival of patients with peritoneal metastasized colorectal cancer dependent on primary tumour nodal status, resection status and peritoneal cancer index scoring system.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan-Maier: 3-year overall survival cytoreductive surgery + hyperthermic intraperitoneal chemotherapy. Kaplan-Maier analysis of 3-year overall survival of patients with peritoneal metastasized colorectal cancer being treated with cytoreductive surgery and oxaliplatin or mitomycin C-hyperthermic intraperitoneal chemotherapy.

Citation: Spiegelberg J, Neeff H, Holzner P, Runkel M, Fichtner-Feigl S, Glatz T. Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer. World J Gastrointest Oncol 2020; 12(8): 903-917
URL: https://www.wjgnet.com/1948-5204/full/v12/i8/903.htm
DOI: https://dx.doi.org/10.4251/wjgo.v12.i8.903